Join | Login







 

HCU Community


Mila, born in October 2018 in Canada, entered a challenging journey with Homocystinuria (HCU) just a week after her birth. Her parents received a phone call revealing her diagnosis of "Classical Homocystinuria," prompting a week-long stay at British Columbia Children’s Hospital. A dedicated medical team worked to stabilize Mila's elevated levels, creating a treatment plan involving B6, Folic Acid, Betaine, formula, and regular blood work. Despite concerns about her diet, potential developmental issues, and the social aspects of growing up with dietary restrictions, Mila adapted well to treatment, displaying resilience and spirit. Her parents emphasize the importance of support and community in navigating the challenges posed by HCU, and their goal is to ensure Mila's condition doesn't define her, allowing her vibrant personality to shine through in various aspects of life.

 

Mila 

(Published in 2023) Shared with permission from full story here

 

Samantha's journey with Homocystinuria (HCU) began with an unconventional diagnosis at the age of 2, as breastfeeding likely delayed symptoms until the introduction of solid foods. Despite early challenges, including seizures and muscle tone loss, Samantha defied predictions and not only survived but learned to walk and talk. Speech therapy addressed some communication difficulties, and she tackled protein limitations to curb stuttering. Samantha surpassed expectations, graduating from high school and pursuing Early Childhood Education. Now a Full-Time Preschool Teacher, she passionately imparts knowledge to young minds. Samantha's zest for life extends to travel, having explored Australia and planned a trip to Egypt. Embracing her genetic condition, she encourages others facing HCU, emphasizing resilience, self-belief, and the transformative power of this unique journey. 

(Published in 2023) Shared with permission from full story here 

 


"Would you like to share your story? Send it to NewsEditor@CanPKU.org

It may be used in the newsletter and/or website. You can advise if you have a preference.

Please also include a signed authorization form so we can use the photo. Click here.